← FDA DRUG APPROVALS

FDA ANDA · ANDA071405

TRAZODONE HYDROCHLORIDE

Sponsor: NATCO

APPLICATION
ANDA071405
TYPE
ANDA
ORIGINAL APPROVAL
1991-02-27
LATEST ACTION
2025-06-24
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TRAZODONE HYDROCHLORIDEDiscontinued
TRAZODONE HYDROCHLORIDE 50MG · TABLET · ORAL

Approval history

2025-06-24Labeling · Supplement 8 · standardAP
2020-04-29Labeling · Supplement 6 · standardAP
2014-07-17Labeling · Supplement 5 · standardAP
1998-02-05Manufacturing (CMC) · Supplement 4AP
1992-01-14Labeling · Supplement 2AP
1991-10-28Manufacturing (CMC) · Supplement 1AP
1991-02-27OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →